Tackling challenges in the development of fixed-dose combinations

Anil Kane from Patheon spoke to Pharmaceutical Technology about the challenges in the development of FDCs and discussed how to integrate quality-by-design (QbD) in the manufacturing process of FDCs.
Apr 02, 2014
Volume 38, Issue 4